Pulmonary 6376111 ? O
and ? ? O
generalized ? ? O
lysosomal ? ? O
storage ? ? O
induced ? ? O
by ? ? O
amphiphilic ? ? O
drugs ? ? O
. ? ? O

Administration 6376111 ? O
of ? ? O
amphiphilic ? ? I-treatment
drugs ? ? I-treatment
to ? ? O
experimental ? ? O
animals ? ? O
causes ? ? O
formation ? ? O
of ? ? O
myelinoid ? ? O
bodies ? ? O
in ? ? O
many ? ? O
cell ? ? O
types ? ? O
, ? ? O
accumulation ? ? O
of ? ? O
foamy ? ? O
macrophages ? ? O
in ? ? O
pulmonary ? ? O
alveoli ? ? O
and ? ? O
pulmonary ? ? I-disease
alveolar ? ? I-disease
proteinosis ? ? I-disease
. ? ? O

These 6376111 ? O
changes ? ? O
are ? ? O
the ? ? O
result ? ? O
of ? ? O
an ? ? O
interaction ? ? O
between ? ? O
the ? ? O
drugs ? ? O
and ? ? O
phospholipids ? ? O
which ? ? O
leads ? ? O
to ? ? O
an ? ? O
alteration ? ? O
in ? ? O
physicochemical ? ? O
properties ? ? O
of ? ? O
the ? ? O
phospholipids ? ? O
. ? ? O

Impairment 6376111 ? O
of ? ? O
the ? ? O
digestion ? ? O
of ? ? O
altered ? ? O
pulmonary ? ? O
secretions ? ? O
in ? ? O
phagosomes ? ? O
of ? ? O
macrophages ? ? O
results ? ? O
in ? ? O
accumulation ? ? O
of ? ? O
foam ? ? O
cells ? ? O
in ? ? O
pulmonary ? ? O
alveoli ? ? O
. ? ? O

Impairment 6376111 ? O
of ? ? O
the ? ? O
metabolism ? ? O
of ? ? O
altered ? ? O
phospholipids ? ? O
removed ? ? O
by ? ? O
autophagy ? ? O
induces ? ? O
an ? ? O
accumulation ? ? O
of ? ? O
myelinoid ? ? O
bodies ? ? O
. ? ? O

The 6376111 ? O
administration ? ? O
of ? ? O
amphiphilic ? ? I-treatment
compounds ? ? I-treatment
thus ? ? O
causes ? ? O
pulmonary ? ? I-disease
intra-alveolar ? ? I-disease
histiocytosis ? ? I-disease
which ? ? O
is ? ? O
a ? ? O
part ? ? O
of ? ? O
a ? ? O
drug-induced ? ? I-disease
lysosomal ? ? I-disease
storage ? ? I-disease
or ? ? I-disease
generalized ? ? I-disease
lipidosis ? ? I-disease
. ? ? O

The 6376111 ? O
accumulation ? ? O
of ? ? O
drug-lipid ? ? O
complexes ? ? O
in ? ? O
myelinoid ? ? O
bodies ? ? O
and ? ? O
in ? ? O
pulmonary ? ? O
foam ? ? O
cells ? ? O
may ? ? O
lead ? ? O
to ? ? O
alteration ? ? O
of ? ? O
cellular ? ? O
functioning ? ? O
and ? ? O
to ? ? O
clinical ? ? O
disease ? ? O
. ? ? O

Currently 6376111 ? O
over ? ? O
50 ? ? O
amphiphilic ? ? I-treatment
drugs ? ? I-treatment
are ? ? O
known ? ? O
. ? ? O

Unique 6376111 ? O
pharmacological ? ? O
properties ? ? O
necessitate ? ? O
clinical ? ? O
use ? ? O
of ? ? O
some ? ? O
of ? ? O
these ? ? O
drugs ? ? O
. ? ? O

The 6376111 ? O
occurrence ? ? O
and ? ? O
severity ? ? O
of ? ? O
potential ? ? O
clinical ? ? O
side ? ? O
effects ? ? O
depend ? ? O
on ? ? O
the ? ? O
nature ? ? O
of ? ? O
each ? ? O
drug ? ? O
, ? ? O
dosage ? ? O
and ? ? O
duration ? ? O
of ? ? O
treatment ? ? O
, ? ? O
simultaneous ? ? O
administration ? ? O
of ? ? O
other ? ? O
drugs ? ? O
and ? ? O
foods ? ? O
, ? ? O
individual ? ? O
metabolic ? ? O
pattern ? ? O
of ? ? O
the ? ? O
patient ? ? O
and ? ? O
other ? ? O
factors ? ? O
. ? ? O

Further 6376111 ? O
studies ? ? O
on ? ? O
factors ? ? O
preventing ? ? O
and ? ? O
potentiating ? ? O
adverse ? ? O
effects ? ? O
of ? ? O
amphiphilic ? ? I-treatment
drugs ? ? I-treatment
are ? ? O
indicated ? ? O
. ? ? O

Familial 8006362 ? I-disease
adrenal ? ? I-disease
insufficiency ? ? I-disease
, ? ? O
achalasia ? ? I-disease
, ? ? O
alacrima ? ? I-disease
, ? ? O
peripheral ? ? I-disease
neuropathy ? ? I-disease
, ? ? O
microcephaly ? ? I-disease
, ? ? O
normal ? ? O
plasma ? ? O
very ? ? O
long ? ? O
chain ? ? O
fatty ? ? O
acids ? ? O
, ? ? O
and ? ? O
normal ? ? O
muscle ? ? O
mitochondrial ? ? O
respiratory ? ? O
chain ? ? O
enzymes ? ? O
. ? ? O

Adrenal 8006362 ? I-disease
insufficiency ? ? I-disease
has ? ? O
been ? ? O
associated ? ? O
with ? ? O
adrenoleukodystrophy ? ? I-disease
and ? ? O
adrenomyeloneuropathy ? ? I-disease
. ? ? O

In 8006362 ? O
these ? ? O
diseases ? ? O
, ? ? O
plasma ? ? O
very ? ? O
long ? ? O
chain ? ? O
fatty ? ? O
acids ? ? O
are ? ? O
elevated ? ? O
. ? ? O

Peripheral 8006362 ? I-disease
neuropathy ? ? I-disease
is ? ? O
frequently ? ? O
seen ? ? O
in ? ? O
adults ? ? O
with ? ? O
adrenomyeloneuropathy ? ? I-disease
. ? ? O

We 8006362 ? O
encountered ? ? O
two ? ? O
first ? ? O
cousins ? ? O
with ? ? O
adrenal ? ? I-disease
insufficiency ? ? I-disease
, ? ? O
who ? ? O
also ? ? O
developed ? ? O
peripheral ? ? I-disease
neuropathy ? ? I-disease
, ? ? O
achalasia ? ? I-disease
, ? ? O
alacrima ? ? I-disease
, ? ? O
and ? ? O
microcephaly ? ? I-disease
. ? ? O

However 8006362 ? O
, ? ? O
plasma ? ? O
very ? ? O
long ? ? O
chain ? ? O
fatty ? ? O
acids ? ? O
, ? ? O
pipecolic ? ? O
acid ? ? O
, ? ? O
phytanic ? ? O
acid ? ? O
, ? ? O
and ? ? O
cranial ? ? O
computed ? ? O
tomographic ? ? O
scan ? ? O
were ? ? O
normal ? ? O
. ? ? O

Muscle 8006362 ? O
mitochondrial ? ? O
respiratory ? ? O
chain ? ? O
enzymes ? ? O
were ? ? O
also ? ? O
normal ? ? O
. ? ? O

This 8006362 ? O
syndrome ? ? O
of ? ? O
adrenal ? ? I-disease
insufficiency ? ? I-disease
, ? ? O
achalasia ? ? I-disease
, ? ? O
alacrima ? ? I-disease
, ? ? O
microcephaly ? ? I-disease
, ? ? O
and ? ? O
peripheral ? ? I-disease
neuropathy ? ? I-disease
is ? ? O
different ? ? O
from ? ? O
either ? ? O
adrenomyeloneuropathy ? ? I-disease
or ? ? O
adrenoleukodystrophy ? ? I-disease
. ? ? O

Carbohydrate-deficient 10571009 ? I-disease
glycoprotein ? ? I-disease
syndrome ? ? I-disease
type ? ? I-disease
IA ? ? I-disease
( ? ? O
phosphomannomutase-deficiency ? ? I-disease
) ? ? O
. ? ? O

The 10571009 ? O
carbohydrate-deficient ? ? I-disease
glycoprotein ? ? I-disease
or ? ? I-disease
CDG ? ? I-disease
syndromes ? ? I-disease
( ? ? O
OMIM ? ? O
212065 ? ? O
) ? ? O
are ? ? O
a ? ? O
recently ? ? O
delineated ? ? O
group ? ? O
of ? ? O
genetic ? ? O
, ? ? O
multisystem ? ? O
diseases ? ? O
with ? ? O
variable ? ? O
dysmorphic ? ? I-disease
features ? ? I-disease
. ? ? O

The 10571009 ? O
known ? ? O
CDG ? ? I-disease
syndromes ? ? I-disease
are ? ? O
characterized ? ? O
by ? ? O
a ? ? O
partial ? ? O
deficiency ? ? O
of ? ? O
the ? ? O
N-linked ? ? O
glycans ? ? O
of ? ? O
secretory ? ? O
glycoproteins ? ? I-gene
, ? ? O
lysosomal ? ? I-gene
enzymes ? ? I-gene
, ? ? O
and ? ? O
probably ? ? O
also ? ? O
membranous ? ? I-gene
glycoproteins ? ? I-gene
. ? ? O

Due 10571009 ? O
to ? ? O
the ? ? O
deficiency ? ? O
of ? ? O
terminal ? ? O
N-acetylneuraminic ? ? O
acid ? ? O
or ? ? O
sialic ? ? O
acid ? ? O
, ? ? O
the ? ? O
glycan ? ? O
changes ? ? O
can ? ? O
be ? ? O
observed ? ? O
in ? ? O
serum ? ? O
transferrin ? ? I-gene
or ? ? O
other ? ? O
glycoproteins ? ? O
using ? ? O
isoelectrofocusing ? ? O
with ? ? O
immunofixation ? ? O
as ? ? O
the ? ? O
most ? ? O
widely ? ? O
used ? ? O
diagnostic ? ? O
technique ? ? O
. ? ? O

Most 10571009 ? O
patients ? ? O
show ? ? O
a ? ? O
serum ? ? O
sialotransferrin ? ? O
pattern ? ? O
characterized ? ? O
by ? ? O
increased ? ? O
di- ? ? O
and ? ? O
asialotransferrin ? ? O
bands ? ? O
( ? ? O
type ? ? O
I ? ? O
pattern ? ? O
) ? ? O
. ? ? O

The 10571009 ? O
majority ? ? O
of ? ? O
patients ? ? O
with ? ? O
type ? ? O
I ? ? O
are ? ? O
phosphomannomutase ? ? I-disease
deficient ? ? I-disease
( ? ? O
type ? ? O
IA ? ? O
) ? ? O
, ? ? O
while ? ? O
in ? ? O
a ? ? O
few ? ? O
other ? ? O
patients ? ? O
, ? ? O
deficiencies ? ? I-disease
of ? ? I-disease
phosphomannose ? ? I-disease
isomerase ? ? I-disease
( ? ? I-disease
type ? ? I-disease
IB ? ? I-disease
) ? ? O
or ? ? O
endoplasmic ? ? I-disease
reticulum ? ? I-disease
glucosyltransferase ? ? I-disease
( ? ? I-disease
type ? ? I-disease
IC ? ? I-disease
) ? ? O
have ? ? O
been ? ? O
demonstrated ? ? O
. ? ? O

This 10571009 ? O
review ? ? O
is ? ? O
an ? ? O
update ? ? O
on ? ? O
CDG ? ? I-disease
syndrome ? ? I-disease
type ? ? I-disease
IA ? ? I-disease
. ? ? O

Ophthalmic 12789572 ? O
manifestations ? ? O
of ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
1a ? ? I-disease
. ? ? O

PURPOSE 12789572 ? O
: ? ? O
To ? ? O
present ? ? O
the ? ? O
ophthalmic ? ? O
manifestations ? ? O
of ? ? O
patients ? ? O
with ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDG-Ia ? ? I-disease
) ? ? O
due ? ? O
to ? ? O
the ? ? O
frequent ? ? O
R141H ? ? O
/ ? ? O
F119L ? ? O
PMM2 ? ? I-gene
genotype ? ? O
. ? ? O

METHODS 12789572 ? O
: ? ? O
Ophthalmic ? ? O
records ? ? O
of ? ? O
23 ? ? O
patients ? ? O
( ? ? O
age ? ? O
: ? ? O
10 ? ? O
months ? ? O
to ? ? O
20 ? ? O
years ? ? O
) ? ? O
were ? ? O
evaluated ? ? O
. ? ? O

They 12789572 ? O
had ? ? O
had ? ? O
at ? ? O
least ? ? O
one ? ? O
ophthalmic ? ? O
reexamination ? ? O
. ? ? O

RESULTS 12789572 ? O
: ? ? O
Measurements ? ? O
of ? ? O
refractive ? ? I-disease
error ? ? I-disease
showed ? ? O
that ? ? O
18 ? ? O
patients ? ? O
were ? ? O
myopic ? ? I-disease
, ? ? O
two ? ? O
were ? ? O
hypermetropic ? ? I-disease
, ? ? O
and ? ? O
three ? ? O
could ? ? O
not ? ? O
be ? ? O
measured ? ? O
. ? ? O

Serial 12789572 ? O
measurements ? ? O
in ? ? O
12 ? ? O
patients ? ? O
indicated ? ? O
a ? ? O
progression ? ? O
towards ? ? O
myopia ? ? I-disease
of ? ? O
0.80 ? ? O
diopters ? ? O
( ? ? O
D ? ? O
) ? ? O
per ? ? O
year ? ? O
. ? ? O

Congenital 12789572 ? I-disease
esotropia ? ? I-disease
and ? ? O
delayed ? ? I-disease
visual ? ? I-disease
maturation ? ? I-disease
( ? ? O
DVM ? ? I-disease
) ? ? O
were ? ? O
consistent ? ? O
findings ? ? O
. ? ? O

Two 12789572 ? O
children ? ? O
developed ? ? O
good ? ? O
visual ? ? O
acuity ? ? O
( ? ? O
VA ? ? O
) ? ? O
, ? ? O
16 ? ? O
had ? ? O
low ? ? I-disease
vision ? ? I-disease
, ? ? O
and ? ? O
five ? ? O
were ? ? O
legally ? ? O
blind ? ? I-disease
. ? ? O

Pallor 12789572 ? I-disease
of ? ? I-disease
the ? ? I-disease
optic ? ? I-disease
disc ? ? I-disease
was ? ? O
noted ? ? O
in ? ? O
five ? ? O
patients ? ? O
. ? ? O

Electroretinography 12789572 ? O
( ? ? O
ERG ? ? O
) ? ? O
performed ? ? O
in ? ? O
nine ? ? O
patients ? ? O
showed ? ? O
reduced ? ? I-disease
rod ? ? I-disease
responses ? ? I-disease
, ? ? O
while ? ? O
cone ? ? O
responses ? ? O
were ? ? O
only ? ? O
slightly ? ? O
reduced ? ? O
. ? ? O

CONCLUSIONS 12789572 ? O
: ? ? O
The ? ? O
present ? ? O
study ? ? O
illustrates ? ? O
the ? ? O
difficulties ? ? O
in ? ? O
examining ? ? O
severely ? ? O
disabled ? ? O
children ? ? O
. ? ? O

Consistent 12789572 ? O
ophthalmic ? ? O
manifestations ? ? O
of ? ? O
CDG-Ia ? ? I-disease
patients ? ? O
due ? ? O
to ? ? O
the ? ? O
R141H ? ? O
/ ? ? O
F119L ? ? O
genotype ? ? O
were ? ? O
congenital ? ? I-disease
esotropia ? ? I-disease
, ? ? O
DVM ? ? I-disease
, ? ? O
and ? ? O
a ? ? O
reduced ? ? I-disease
rod ? ? I-disease
response ? ? I-disease
in ? ? O
ERG-examined ? ? O
patients ? ? O
. ? ? O

The 12789572 ? O
vast ? ? O
majority ? ? O
of ? ? O
patients ? ? O
had ? ? O
reduced ? ? O
VA ? ? O
and ? ? O
developed ? ? O
myopia ? ? I-disease
. ? ? O

We 12789572 ? O
speculate ? ? O
that ? ? O
there ? ? O
is ? ? O
a ? ? O
relationship ? ? O
between ? ? O
the ? ? O
glycosylation ? ? O
defect ? ? O
in ? ? O
CDG-Ia ? ? I-disease
and ? ? O
the ? ? O
development ? ? O
of ? ? O
myopia ? ? I-disease
. ? ? O

We 12789572 ? O
recommend ? ? O
that ? ? O
CDG-Ia ? ? I-disease
patients ? ? O
be ? ? O
followed ? ? O
annually ? ? O
by ? ? O
an ? ? O
ophthalmologist ? ? O
. ? ? O

Congenital 15257005 ? I-disease
alacrima ? ? I-disease
in ? ? O
Pierre ? ? I-disease
Robin ? ? I-disease
sequence ? ? I-disease
. ? ? O

PURPOSE 15257005 ? O
: ? ? O
To ? ? O
report ? ? O
the ? ? O
presence ? ? O
of ? ? O
congenital ? ? I-disease
alacrima ? ? I-disease
in ? ? O
a ? ? O
patient ? ? O
with ? ? O
Pierre ? ? I-disease
Robin ? ? I-disease
( ? ? O
PR ? ? I-disease
) ? ? O
sequence ? ? O
. ? ? O

METHODS 15257005 ? O
: ? ? O
A ? ? O
6-month-old ? ? O
child ? ? O
with ? ? O
diagnosed ? ? O
PR ? ? I-disease
sequence ? ? I-disease
presented ? ? O
to ? ? O
us ? ? O
with ? ? O
dysfunctional ? ? I-disease
lacrimation ? ? I-disease
present ? ? O
since ? ? O
birth ? ? O
. ? ? O

The 15257005 ? O
child ? ? O
subsequently ? ? O
developed ? ? O
bilateral ? ? I-disease
corneal ? ? I-disease
ulcers ? ? I-disease
. ? ? O

This 15257005 ? O
unusual ? ? O
presentation ? ? O
and ? ? O
its ? ? O
management ? ? O
are ? ? O
described ? ? O
in ? ? O
detail ? ? O
, ? ? O
and ? ? O
other ? ? O
ocular ? ? O
associations ? ? O
of ? ? O
the ? ? O
PR ? ? I-disease
sequence ? ? I-disease
are ? ? O
discussed ? ? O
. ? ? O

RESULTS 15257005 ? O
: ? ? O
Continuous ? ? I-treatment
tear ? ? I-treatment
supplementation ? ? I-treatment
and ? ? O
appropriate ? ? O
treatment ? ? O
with ? ? O
antibiotics ? ? I-treatment
controlled ? ? O
the ? ? O
microbial ? ? I-disease
infection ? ? I-disease
. ? ? O

However 15257005 ? O
, ? ? O
the ? ? O
long-term ? ? O
prognosis ? ? O
for ? ? O
visual ? ? O
rehabilitation ? ? O
remained ? ? O
poor ? ? O
in ? ? O
this ? ? O
patient ? ? O
because ? ? O
of ? ? O
the ? ? O
presence ? ? O
of ? ? O
central ? ? I-disease
corneal ? ? I-disease
opacities ? ? I-disease
, ? ? O
persistent ? ? I-disease
dry ? ? I-disease
eye ? ? I-disease
, ? ? O
which ? ? O
would ? ? O
preclude ? ? O
future ? ? O
optical ? ? I-treatment
keratoplasty ? ? I-treatment
, ? ? O
and ? ? O
possible ? ? O
sensory ? ? I-treatment
deprivation ? ? I-treatment
amblyopia ? ? I-treatment
. ? ? O

CONCLUSIONS 15257005 ? O
: ? ? O
Alacrima ? ? I-disease
can ? ? O
cause ? ? O
significant ? ? O
ocular ? ? I-disease
morbidity ? ? I-disease
, ? ? O
because ? ? O
persistent ? ? I-disease
ocular ? ? I-disease
surface ? ? I-disease
dryness ? ? I-disease
can ? ? O
be ? ? O
very ? ? O
difficult ? ? O
to ? ? O
manage ? ? O
. ? ? O

Lifelong 15257005 ? O
tear ? ? I-treatment
supplementation ? ? I-treatment
may ? ? O
be ? ? O
necessary ? ? O
. ? ? O

The 15257005 ? O
association ? ? O
or ? ? O
coexistence ? ? O
of ? ? O
congenital ? ? I-disease
alacrima ? ? I-disease
and ? ? O
the ? ? O
Pierre ? ? I-disease
Robin ? ? I-disease
sequence ? ? I-disease
has ? ? O
not ? ? O
been ? ? O
described ? ? O
before ? ? O
this ? ? O
report ? ? O
. ? ? O

Skeletal 16423609 ? I-disease
dysplasia ? ? I-disease
and ? ? O
myelopathy ? ? I-disease
in ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? O
glycosylation ? ? O
type ? ? O
IA ? ? O
. ? ? O

We 16423609 ? O
report ? ? O
on ? ? O
a ? ? O
boy ? ? O
with ? ? O
a ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
Ia ? ? O
and ? ? O
a ? ? O
severe ? ? I-disease
narrowing ? ? I-disease
of ? ? I-disease
the ? ? I-disease
spinal ? ? I-disease
canal ? ? I-disease
caused ? ? O
by ? ? O
atlantoaxial ? ? O
subluxation ? ? O
with ? ? O
anterior ? ? O
displacement ? ? O
of ? ? O
C1 ? ? O
. ? ? O

C1-laminectomy 16423609 ? O
improved ? ? O
the ? ? O
progressive ? ? O
paresis ? ? O
. ? ? O

Progressive 16423609 ? I-disease
paresis ? ? I-disease
caused ? ? O
by ? ? O
spinal ? ? O
cord ? ? O
compression ? ? O
is ? ? O
a ? ? O
hitherto ? ? O
unrecognized ? ? O
complication ? ? O
in ? ? O
patients ? ? O
with ? ? O
CDG-Ia ? ? O
. ? ? O

Risk 18093857 ? O
assessment ? ? O
of ? ? O
acute ? ? O
vascular ? ? O
events ? ? O
in ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
. ? ? O

The 18093857 ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDG-Ia ? ? I-disease
) ? ? O
presents ? ? O
a ? ? O
broad ? ? O
clinical ? ? O
spectrum ? ? O
. ? ? O

Some 18093857 ? O
patients ? ? O
suffer ? ? O
from ? ? O
acute ? ? I-disease
vascular ? ? I-disease
events ? ? I-disease
( ? ? O
thrombosis ? ? I-disease
and ? ? O
bleeding ? ? O
) ? ? O
and ? ? O
stroke-like ? ? O
events ? ? O
. ? ? O

No 18093857 ? O
correlations ? ? O
have ? ? O
been ? ? O
made ? ? O
between ? ? O
the ? ? O
marked ? ? O
hemostasis ? ? I-disease
abnormalities ? ? I-disease
of ? ? O
CDG-Ia ? ? I-disease
and ? ? O
the ? ? O
occurrence ? ? O
of ? ? O
acute ? ? I-disease
vascular ? ? I-disease
events ? ? I-disease
. ? ? O

We 18093857 ? O
report ? ? O
on ? ? O
6 ? ? O
patients ? ? O
with ? ? O
CDG-Ia ? ? I-disease
presenting ? ? O
vascular ? ? I-disease
events ? ? I-disease
, ? ? O
then ? ? O
we ? ? O
analyze ? ? O
the ? ? O
clinical ? ? O
and ? ? O
hemostasis ? ? O
data ? ? O
of ? ? O
39 ? ? O
CDG-Ia ? ? I-disease
patients ? ? O
described ? ? O
in ? ? O
the ? ? O
literature ? ? O
, ? ? O
17 ? ? O
with ? ? O
vascular ? ? I-disease
events ? ? I-disease
( ? ? O
E ? ? O
) ? ? O
and ? ? O
21 ? ? O
unscathed ? ? O
from ? ? O
any ? ? O
event ? ? O
( ? ? O
EF ? ? O
) ? ? O
, ? ? O
to ? ? O
determine ? ? O
the ? ? O
risk ? ? O
factors ? ? O
for ? ? O
acute ? ? I-disease
vascular ? ? I-disease
events ? ? I-disease
in ? ? O
CDG-Ia ? ? I-disease
. ? ? O

Acute 18093857 ? I-disease
vascular ? ? I-disease
events ? ? I-disease
occurred ? ? O
in ? ? O
patients ? ? O
younger ? ? O
than ? ? O
15 ? ? O
years ? ? O
, ? ? O
especially ? ? O
with ? ? O
fever ? ? I-disease
and ? ? O
prolonged ? ? I-disease
immobilization ? ? I-disease
. ? ? O

Hemostasis 18093857 ? O
and ? ? O
liver ? ? O
cytolysis ? ? O
were ? ? O
statistically ? ? O
abnormal ? ? O
in ? ? O
patients ? ? O
younger ? ? O
than ? ? O
5 ? ? O
years ? ? O
whatever ? ? O
the ? ? O
occurrence ? ? O
of ? ? O
vascular ? ? I-disease
events ? ? I-disease
and ? ? O
they ? ? O
normalized ? ? O
with ? ? O
time ? ? O
. ? ? O

Higher 18093857 ? O
factors ? ? O
VIII ? ? O
and ? ? O
IX ? ? O
activities ? ? O
were ? ? O
statistically ? ? O
observed ? ? O
in ? ? O
the ? ? O
E ? ? O
cluster ? ? O
( ? ? O
p=0.03 ? ? O
) ? ? O
compared ? ? O
to ? ? O
the ? ? O
EF ? ? O
cluster ? ? O
. ? ? O

The 18093857 ? O
activity ? ? O
/ ? ? O
antigenicity ? ? O
ratio ? ? O
for ? ? O
protein ? ? O
C ? ? O
( ? ? O
p=0.02 ? ? O
) ? ? O
was ? ? O
also ? ? O
higher ? ? O
in ? ? O
the ? ? O
E ? ? O
group ? ? O
. ? ? O

CDG-Ia 18093857 ? I-disease
patients ? ? O
younger ? ? O
than ? ? O
15 ? ? O
years ? ? O
old ? ? O
are ? ? O
at ? ? O
risk ? ? O
of ? ? O
acute ? ? I-disease
vascular ? ? I-disease
events ? ? I-disease
. ? ? O

The 18093857 ? O
paradoxical ? ? O
results-abnormal ? ? O
VIII ? ? O
and ? ? O
IX ? ? O
factors ? ? O
in ? ? O
EF ? ? O
patients ? ? O
and ? ? O
normal ? ? O
results ? ? O
in ? ? O
E ? ? O
patients ? ? O
, ? ? O
while ? ? O
XI ? ? O
, ? ? O
antithrombin ? ? O
, ? ? O
protein ? ? I-gene
C ? ? I-gene
, ? ? O
ASAT ? ? O
and ? ? O
ALAT ? ? O
are ? ? O
abnormal ? ? O
in ? ? O
both ? ? O
groups ? ? O
, ? ? O
could ? ? O
suggest ? ? O
a ? ? O
disequilibrium ? ? O
between ? ? O
prothrombotic ? ? O
and ? ? O
antithrombotic ? ? O
factors ? ? O
in ? ? O
the ? ? O
E ? ? O
group ? ? O
. ? ? O

Vascular 18093857 ? I-disease
events ? ? I-disease
may ? ? O
also ? ? O
occur ? ? O
in ? ? O
patients ? ? O
where ? ? O
glycoproteins ? ? O
are ? ? O
proportionally ? ? O
more ? ? O
hypoglycosylated ? ? O
, ? ? O
particularly ? ? O
protein ? ? I-gene
C ? ? I-gene
. ? ? O

Different 18485644 ? O
neuroradiological ? ? O
findings ? ? O
during ? ? O
two ? ? O
stroke-like ? ? I-disease
episodes ? ? I-disease
in ? ? O
a ? ? O
patient ? ? O
with ? ? O
a ? ? O
congenital ? ? I-disease
disorder ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
. ? ? O

Congenital 18485644 ? I-disease
disorders ? ? I-disease
of ? ? I-disease
glycosylation ? ? I-disease
type ? ? I-disease
Ia ? ? I-disease
( ? ? O
CDG-Ia ? ? I-disease
) ? ? O
are ? ? O
the ? ? O
most ? ? O
common ? ? O
type ? ? O
of ? ? O
CDG ? ? I-disease
and ? ? O
are ? ? O
characterized ? ? O
by ? ? O
liver ? ? I-disease
dysfunction ? ? I-disease
, ? ? O
coagulation ? ? I-disease
disorders ? ? I-disease
, ? ? O
mental ? ? I-disease
retardation ? ? I-disease
, ? ? O
hypotonia ? ? I-disease
, ? ? O
cerebellar ? ? I-disease
dysfunction ? ? I-disease
, ? ? O
polyneuropathy ? ? I-disease
, ? ? O
seizures ? ? I-disease
, ? ? O
and ? ? O
stroke-like ? ? I-disease
episodes ? ? I-disease
. ? ? O

Stroke-like 18485644 ? I-disease
episodes ? ? I-disease
occur ? ? O
in ? ? O
40-55 ? ? O
% ? ? O
of ? ? O
cases ? ? O
, ? ? O
but ? ? O
their ? ? O
etiology ? ? O
is ? ? O
not ? ? O
fully ? ? O
understood ? ? O
. ? ? O

Although 18485644 ? O
it ? ? O
has ? ? O
been ? ? O
stated ? ? O
that ? ? O
an ? ? O
epileptic ? ? I-disease
process ? ? I-disease
may ? ? O
cause ? ? O
the ? ? O
stroke-like ? ? I-disease
episodes ? ? I-disease
, ? ? O
there ? ? O
is ? ? O
no ? ? O
clear ? ? O
evidence ? ? O
of ? ? O
ischemic ? ? I-disease
stroke ? ? I-disease
. ? ? O

Here 18485644 ? O
, ? ? O
we ? ? O
describe ? ? O
two ? ? O
stroke-like ? ? I-disease
episodes ? ? I-disease
in ? ? O
a ? ? O
patient ? ? O
with ? ? O
CDG ? ? I-disease
. ? ? O

We 18485644 ? O
performed ? ? O
radiological ? ? O
studies ? ? O
during ? ? O
each ? ? O
episode ? ? O
and ? ? O
obtained ? ? O
two ? ? O
distinct ? ? O
magnetic ? ? O
resonance ? ? O
imaging ? ? O
( ? ? O
MRI ? ? O
) ? ? O
findings ? ? O
: ? ? O
one ? ? O
revealed ? ? O
an ? ? O
ischemic ? ? I-disease
stroke ? ? I-disease
, ? ? O
and ? ? O
the ? ? O
other ? ? O
demonstrated ? ? O
marked ? ? O
edema ? ? I-disease
followed ? ? O
by ? ? O
focal ? ? I-disease
necrosis ? ? I-disease
. ? ? O

This 18485644 ? O
is ? ? O
the ? ? O
first ? ? O
direct ? ? O
evidence ? ? O
of ? ? O
ischemic ? ? I-disease
stroke ? ? I-disease
, ? ? O
and ? ? O
we ? ? O
report ? ? O
that ? ? O
another ? ? O
process ? ? O
may ? ? O
affect ? ? O
the ? ? O
etiology ? ? O
in ? ? O
the ? ? O
same ? ? O
patient ? ? O
. ? ? O

Eeyarestatin 19903691 ? I-treatment
I ? ? I-treatment
inhibits ? ? O
Sec61-mediated ? ? O
protein ? ? O
translocation ? ? O
at ? ? O
the ? ? O
endoplasmic ? ? O
reticulum ? ? O
. ? ? O

Production 19903691 ? O
and ? ? O
trafficking ? ? O
of ? ? O
proteins ? ? O
entering ? ? O
the ? ? O
secretory ? ? O
pathway ? ? O
of ? ? O
eukaryotic ? ? O
cells ? ? O
is ? ? O
coordinated ? ? O
at ? ? O
the ? ? O
endoplasmic ? ? O
reticulum ? ? O
( ? ? O
ER ? ? O
) ? ? O
in ? ? O
a ? ? O
process ? ? O
that ? ? O
begins ? ? O
with ? ? O
protein ? ? O
translocation ? ? O
via ? ? O
the ? ? O
membrane-embedded ? ? O
ER ? ? O
translocon ? ? O
. ? ? O

The 19903691 ? O
same ? ? O
complex ? ? O
is ? ? O
also ? ? O
responsible ? ? O
for ? ? O
the ? ? O
co-translational ? ? O
integration ? ? O
of ? ? O
membrane ? ? O
proteins ? ? O
and ? ? O
orchestrates ? ? O
polypeptide ? ? O
modifications ? ? O
that ? ? O
are ? ? O
often ? ? O
essential ? ? O
for ? ? O
protein ? ? O
function ? ? O
. ? ? O

We 19903691 ? O
now ? ? O
show ? ? O
that ? ? O
the ? ? O
previously ? ? O
identified ? ? O
inhibitor ? ? O
of ? ? O
ER-associated ? ? O
degradation ? ? O
( ? ? O
ERAD ? ? O
) ? ? O
eeyarestatin ? ? O
1 ? ? O
( ? ? O
ES ? ? O
( ? ? O
I ? ? O
) ? ? O
) ? ? O
is ? ? O
a ? ? O
potent ? ? O
inhibitor ? ? O
of ? ? O
protein ? ? O
translocation ? ? O
. ? ? O

We 19903691 ? O
have ? ? O
characterised ? ? O
this ? ? O
inhibition ? ? O
of ? ? O
ER ? ? O
translocation ? ? O
both ? ? O
in ? ? O
vivo ? ? O
and ? ? O
in ? ? O
vitro ? ? O
, ? ? O
and ? ? O
provide ? ? O
evidence ? ? O
that ? ? O
ES ? ? O
( ? ? O
I ? ? O
) ? ? O
targets ? ? O
a ? ? O
component ? ? O
of ? ? O
the ? ? O
Sec61 ? ? I-gene
complex ? ? O
that ? ? O
forms ? ? O
the ? ? O
membrane ? ? O
pore ? ? O
of ? ? O
the ? ? O
ER ? ? O
translocon ? ? O
. ? ? O

Further 19903691 ? O
analyses ? ? O
show ? ? O
that ? ? O
ES ? ? O
( ? ? O
I ? ? O
) ? ? O
acts ? ? O
by ? ? O
preventing ? ? O
the ? ? O
transfer ? ? O
of ? ? O
the ? ? O
nascent ? ? O
polypeptide ? ? O
from ? ? O
the ? ? O
co-translational ? ? O
targeting ? ? O
machinery ? ? O
to ? ? O
the ? ? O
Sec61 ? ? I-gene
complex ? ? O
. ? ? O

These 19903691 ? O
results ? ? O
identify ? ? O
a ? ? O
novel ? ? O
effect ? ? O
of ? ? O
ES ? ? O
( ? ? O
I ? ? O
) ? ? O
, ? ? O
and ? ? O
suggest ? ? O
that ? ? O
the ? ? O
drug ? ? O
can ? ? O
modulate ? ? O
canonical ? ? O
protein ? ? O
transport ? ? O
from ? ? O
the ? ? O
cytosol ? ? O
into ? ? O
the ? ? O
mammalian ? ? O
ER ? ? O
both ? ? O
in ? ? O
vitro ? ? O
and ? ? O
in ? ? O
vivo ? ? O
. ? ? O

Hsp72 21204265 ? O
is ? ? O
an ? ? O
early ? ? O
and ? ? O
sensitive ? ? O
biomarker ? ? O
to ? ? O
detect ? ? O
acute ? ? O
kidney ? ? O
injury ? ? O
. ? ? O

This 21204265 ? O
study ? ? O
was ? ? O
designed ? ? O
to ? ? O
assess ? ? O
whether ? ? O
heat ? ? O
shock ? ? O
protein ? ? O
Hsp72 ? ? O
is ? ? O
an ? ? O
early ? ? O
and ? ? O
sensitive ? ? O
biomarker ? ? O
of ? ? O
acute ? ? O
kidney ? ? O
injury ? ? O
( ? ? O
AKI ? ? O
) ? ? O
as ? ? O
well ? ? O
as ? ? O
to ? ? O
monitor ? ? O
a ? ? O
renoprotective ? ? O
strategy ? ? O
. ? ? O

Seventy-two 21204265 ? O
Wistar ? ? O
rats ? ? O
were ? ? O
divided ? ? O
into ? ? O
six ? ? O
groups ? ? O
: ? ? O
sham-operated ? ? O
and ? ? O
rats ? ? O
subjected ? ? O
to ? ? O
10 ? ? O
, ? ? O
20 ? ? O
, ? ? O
30 ? ? O
, ? ? O
45 ? ? O
and ? ? O
60 ? ? O
min ? ? O
of ? ? O
bilateral ? ? O
ischemia ? ? O
( ? ? O
I ? ? O
) ? ? O
and ? ? O
24 ? ? O
h ? ? O
of ? ? O
reperfusion ? ? O
( ? ? O
R ? ? O
) ? ? O
. ? ? O

Different 21204265 ? O
times ? ? O
of ? ? O
reperfusion ? ? O
( ? ? O
3 ? ? O
, ? ? O
6 ? ? O
, ? ? O
9 ? ? O
, ? ? O
12 ? ? O
, ? ? O
18 ? ? O
, ? ? O
24 ? ? O
, ? ? O
48 ? ? O
, ? ? O
72 ? ? O
, ? ? O
96 ? ? O
and ? ? O
120 ? ? O
h ? ? O
) ? ? O
were ? ? O
also ? ? O
evaluated ? ? O
in ? ? O
30 ? ? O
other ? ? O
rats ? ? O
subjected ? ? O
to ? ? O
30 ? ? O
min ? ? O
of ? ? O
ischemia ? ? O
. ? ? O

Hsp72 21204265 ? O
messenger ? ? O
RNA ? ? O
( ? ? O
mRNA ? ? O
) ? ? O
and ? ? O
protein ? ? O
levels ? ? O
were ? ? O
determined ? ? O
in ? ? O
both ? ? O
kidney ? ? O
and ? ? O
urine ? ? O
. ? ? O

Hsp72-specificity 21204265 ? O
as ? ? O
a ? ? O
biomarker ? ? O
to ? ? O
assess ? ? O
the ? ? O
success ? ? O
of ? ? O
a ? ? O
renoprotective ? ? O
intervention ? ? O
was ? ? O
evaluated ? ? O
in ? ? O
rats ? ? O
treated ? ? O
with ? ? O
different ? ? O
doses ? ? O
of ? ? O
spironolactone ? ? I-treatment
before ? ? O
I ? ? O
/ ? ? O
R. ? ? O
Renal ? ? O
Hsp72 ? ? O
mRNA ? ? O
and ? ? O
protein ? ? O
, ? ? O
as ? ? O
well ? ? O
as ? ? O
urinary ? ? O
Hsp72 ? ? O
levels ? ? O
, ? ? O
gradually ? ? O
increased ? ? O
relative ? ? O
to ? ? O
the ? ? O
extent ? ? O
of ? ? O
renal ? ? I-disease
injury ? ? I-disease
induced ? ? O
by ? ? O
different ? ? O
periods ? ? O
of ? ? O
ischemia ? ? O
quantified ? ? O
by ? ? O
histomorphometry ? ? O
as ? ? O
a ? ? O
benchmark ? ? O
of ? ? O
kidney ? ? O
damage ? ? O
. ? ? O

Urinary 21204265 ? O
Hsp72 ? ? O
increased ? ? O
significantly ? ? O
after ? ? O
3 ? ? O
h ? ? O
and ? ? O
continued ? ? O
rising ? ? O
until ? ? O
18 ? ? O
h ? ? O
, ? ? O
followed ? ? O
by ? ? O
restoration ? ? O
after ? ? O
120 ? ? O
h ? ? O
of ? ? O
reperfusion ? ? O
in ? ? O
accord ? ? O
with ? ? O
histopathological ? ? O
findings ? ? O
. ? ? O

Spironolactone 21204265 ? I-treatment
renoprotection ? ? O
was ? ? O
associated ? ? O
with ? ? O
normalization ? ? O
of ? ? O
urinary ? ? O
Hsp72 ? ? I-gene
levels ? ? O
. ? ? O

Accordingly 21204265 ? O
, ? ? O
urinary ? ? O
Hsp72 ? ? I-gene
was ? ? O
significantly ? ? O
increased ? ? O
in ? ? O
patients ? ? O
with ? ? O
clinical ? ? O
AKI ? ? O
before ? ? O
serum ? ? O
creatinine ? ? O
elevation ? ? O
. ? ? O

Our 21204265 ? O
results ? ? O
show ? ? O
that ? ? O
urinary ? ? O
Hsp72 ? ? I-gene
is ? ? O
a ? ? O
useful ? ? O
biomarker ? ? O
for ? ? O
early ? ? O
detection ? ? O
and ? ? O
stratification ? ? O
of ? ? O
AKI ? ? O
. ? ? O

In 21204265 ? O
addition ? ? O
, ? ? O
urinary ? ? O
Hsp72 ? ? I-gene
levels ? ? O
are ? ? O
sensitive ? ? O
enough ? ? O
to ? ? O
monitor ? ? O
therapeutic ? ? O
interventions ? ? O
and ? ? O
the ? ? O
degree ? ? O
of ? ? O
tubular ? ? O
recovery ? ? O
following ? ? O
an ? ? O
I ? ? O
/ ? ? O
R ? ? O
insult ? ? O
. ? ? O

Critical 22216170 ? O
role ? ? O
of ? ? O
VCP ? ? I-gene
/ ? ? O
p97 ? ? I-gene
in ? ? O
the ? ? O
pathogenesis ? ? O
and ? ? O
progression ? ? O
of ? ? O
non-small ? ? I-disease
cell ? ? I-disease
lung ? ? I-disease
carcinoma ? ? I-disease
. ? ? O

BACKGROUND 22216170 ? O
: ? ? O
Valosin-containing ? ? I-gene
protein ? ? I-gene
( ? ? O
VCP ? ? O
) ? ? O
/ ? ? O
p97 ? ? I-gene
is ? ? O
an ? ? O
AAA ? ? O
ATPase ? ? O
molecular ? ? O
chaperone ? ? O
that ? ? O
regulates ? ? O
vital ? ? O
cellular ? ? O
functions ? ? O
and ? ? O
protein-processing ? ? O
. ? ? O

A 22216170 ? O
recent ? ? O
study ? ? O
indicated ? ? O
that ? ? O
VCP ? ? O
expression ? ? O
levels ? ? O
are ? ? O
correlated ? ? O
with ? ? O
prognosis ? ? O
and ? ? O
progression ? ? O
of ? ? O
non-small ? ? I-disease
cell ? ? I-disease
lung ? ? I-disease
carcinoma ? ? I-disease
( ? ? O
NSCLC ? ? O
) ? ? O
. ? ? O

We 22216170 ? O
not ? ? O
only ? ? O
verified ? ? O
these ? ? O
findings ? ? O
but ? ? O
also ? ? O
identified ? ? O
the ? ? O
specific ? ? O
role ? ? O
of ? ? O
VCP ? ? I-gene
in ? ? O
NSCLC ? ? I-disease
pathogenesis ? ? O
and ? ? O
progression ? ? O
. ? ? O

METHODOLOGY 22216170 ? O
/ ? ? O
PRINCIPAL ? ? O
FINDINGS ? ? O
: ? ? O
Our ? ? O
results ? ? O
show ? ? O
that ? ? O
VCP ? ? O
is ? ? O
significantly ? ? O
overexpressed ? ? O
in ? ? O
non-small ? ? I-disease
cell ? ? I-disease
lung ? ? I-disease
carcinoma ? ? I-disease
( ? ? O
NSCLC ? ? O
) ? ? O
as ? ? O
compared ? ? O
to ? ? O
normal ? ? O
tissues ? ? O
and ? ? O
cell ? ? O
lines ? ? O
( ? ? O
p ? ? O
< ? ? O
0.001 ? ? O
) ? ? O
. ? ? O

Moreover 22216170 ? O
, ? ? O
we ? ? O
observed ? ? O
the ? ? O
corresponding ? ? O
accumulation ? ? O
of ? ? O
ubiquitinated-proteins ? ? O
in ? ? O
NSCLC ? ? I-disease
cell ? ? O
lines ? ? O
and ? ? O
tissues ? ? O
as ? ? O
compared ? ? O
to ? ? O
the ? ? O
normal ? ? O
controls ? ? O
. ? ? O

VCP 22216170 ? I-gene
inhibition ? ? O
by ? ? O
si ? ? O
/ ? ? O
shRNA ? ? O
or ? ? O
small-molecule ? ? O
( ? ? O
Eeyarestatin ? ? O
I ? ? O
, ? ? O
EerI ? ? O
) ? ? O
significantly ? ? O
( ? ? O
p ? ? O
< ? ? O
0.05 ? ? O
, ? ? O
p ? ? O
< ? ? O
0.00007 ? ? O
) ? ? O
suppressed ? ? O
H1299 ? ? O
proliferation ? ? O
and ? ? O
migration ? ? O
but ? ? O
induced ? ? O
( ? ? O
p ? ? O
< ? ? O
0.00001 ? ? O
) ? ? O
apoptosis ? ? O
. ? ? O

Cell 22216170 ? O
cycle ? ? O
analysis ? ? O
by ? ? O
flow ? ? O
cytometry ? ? O
verified ? ? O
this ? ? O
data ? ? O
and ? ? O
shows ? ? O
that ? ? O
VCP ? ? O
inhibition ? ? O
significantly ? ? O
( ? ? O
p ? ? O
< ? ? O
0.001 ? ? O
, ? ? O
p ? ? O
< ? ? O
0.003 ? ? O
) ? ? O
induced ? ? O
cell ? ? O
cycle ? ? O
arrest ? ? O
in ? ? O
the ? ? O
G0 ? ? O
/ ? ? O
G1 ? ? O
phases ? ? O
. ? ? O

We 22216170 ? O
also ? ? O
found ? ? O
that ? ? O
VCP ? ? I-gene
directly ? ? O
regulates ? ? O
p53 ? ? O
and ? ? O
NFkappaB ? ? O
protein ? ? O
levels ? ? O
as ? ? O
a ? ? O
potential ? ? O
mechanism ? ? O
to ? ? O
control ? ? O
tumor ? ? O
cell ? ? O
proliferation ? ? O
and ? ? O
progression ? ? O
. ? ? O

Finally 22216170 ? O
, ? ? O
we ? ? O
evaluated ? ? O
the ? ? O
therapeutic ? ? O
potential ? ? O
of ? ? O
VCP ? ? I-gene
inhibition ? ? O
and ? ? O
observed ? ? O
significantly ? ? O
reduced ? ? O
NSCLC ? ? I-disease
tumor ? ? I-disease
growth ? ? O
in ? ? O
both ? ? O
in ? ? O
vitro ? ? O
and ? ? O
xenograft ? ? O
murine ? ? O
( ? ? O
athymic-nude ? ? O
) ? ? O
models ? ? O
after ? ? O
EerI ? ? O
treatment ? ? O
( ? ? O
p ? ? O
< ? ? O
0.05 ? ? O
) ? ? O
. ? ? O

CONCLUSIONS 22216170 ? O
/ ? ? O
SIGNIFICANCE ? ? O
: ? ? O
Thus ? ? O
, ? ? O
targeting ? ? O
VCP ? ? O
in ? ? O
NSCLC ? ? O
may ? ? O
provide ? ? O
a ? ? O
novel ? ? O
strategy ? ? O
to ? ? O
restore ? ? O
p53 ? ? I-gene
and ? ? O
NFkappaB ? ? O
levels ? ? O
and ? ? O
ameliorate ? ? O
the ? ? O
growth ? ? O
and ? ? O
tumorigenicity ? ? O
, ? ? O
leading ? ? O
to ? ? O
improved ? ? O
clinical ? ? O
outcomes ? ? O
. ? ? O

Approaches 22983704 ? O
to ? ? O
homozygosity ? ? O
mapping ? ? O
and ? ? O
exome ? ? O
sequencing ? ? O
for ? ? O
the ? ? O
identification ? ? O
of ? ? O
novel ? ? O
types ? ? O
of ? ? O
CDG ? ? I-disease
. ? ? O

In 22983704 ? O
the ? ? O
past ? ? O
decade ? ? O
, ? ? O
the ? ? O
identification ? ? O
of ? ? O
most ? ? O
genes ? ? O
involved ? ? O
in ? ? O
Congenital ? ? I-disease
Disorders ? ? I-disease
of ? ? I-disease
Glycosylation ? ? I-disease
( ? ? O
CDG ? ? I-disease
) ? ? O
( ? ? O
type ? ? O
I ? ? O
) ? ? O
was ? ? O
achieved ? ? O
by ? ? O
a ? ? O
combination ? ? O
of ? ? O
biochemical ? ? O
, ? ? O
cell ? ? O
biological ? ? O
and ? ? O
glycobiological ? ? O
investigations ? ? O
. ? ? O

This 22983704 ? O
has ? ? O
been ? ? O
truly ? ? O
successful ? ? O
for ? ? O
CDG-I ? ? I-disease
, ? ? O
because ? ? O
the ? ? O
candidate ? ? O
genes ? ? O
could ? ? O
be ? ? O
selected ? ? O
on ? ? O
the ? ? O
basis ? ? O
of ? ? O
the ? ? O
homology ? ? O
of ? ? O
the ? ? O
synthetic ? ? O
pathway ? ? O
of ? ? O
the ? ? O
dolichol ? ? I-treatment
linked ? ? O
oligosaccharide ? ? O
in ? ? O
human ? ? O
and ? ? O
yeast ? ? O
. ? ? O

On 22983704 ? O
the ? ? O
contrary ? ? O
, ? ? O
only ? ? O
a ? ? O
few ? ? O
CDG-II ? ? I-disease
defects ? ? O
were ? ? O
elucidated ? ? O
, ? ? O
be ? ? O
it ? ? O
that ? ? O
some ? ? O
of ? ? O
the ? ? O
discoveries ? ? O
represent ? ? O
wonderful ? ? O
breakthroughs ? ? O
, ? ? O
like ? ? O
e.g ? ? O
, ? ? O
the ? ? O
identification ? ? O
of ? ? O
the ? ? O
COG ? ? O
defects ? ? O
. ? ? O

In 22983704 ? O
general ? ? O
, ? ? O
many ? ? O
rare ? ? O
genetic ? ? I-disease
defects ? ? I-disease
have ? ? O
been ? ? O
identified ? ? O
by ? ? O
positional ? ? O
cloning ? ? O
. ? ? O

However 22983704 ? O
, ? ? O
only ? ? O
a ? ? O
few ? ? O
types ? ? O
of ? ? O
CDG ? ? I-disease
have ? ? O
effectively ? ? O
been ? ? O
elucidated ? ? O
by ? ? O
linkage ? ? O
analysis ? ? O
and ? ? O
so-called ? ? O
reverse ? ? O
genetics ? ? O
. ? ? O

The 22983704 ? O
reason ? ? O
is ? ? O
that ? ? O
the ? ? O
families ? ? O
were ? ? O
relatively ? ? O
small ? ? O
and ? ? O
could-except ? ? O
for ? ? O
CDG-PMM2-not ? ? O
be ? ? O
pooled ? ? O
for ? ? O
analysis ? ? O
. ? ? O

Hence 22983704 ? O
, ? ? O
a ? ? O
large ? ? O
number ? ? O
of ? ? O
CDG ? ? I-disease
cases ? ? O
has ? ? O
long ? ? O
remained ? ? O
unsolved ? ? O
because ? ? O
the ? ? O
search ? ? O
for ? ? O
the ? ? O
culprit ? ? O
gene ? ? O
was ? ? O
very ? ? O
laborious ? ? O
, ? ? O
due ? ? O
to ? ? O
the ? ? O
heterogeneous ? ? O
phenotype ? ? O
and ? ? O
the ? ? O
myriad ? ? O
of ? ? O
candidate ? ? O
defects ? ? O
. ? ? O

This 22983704 ? O
has ? ? O
changed ? ? O
when ? ? O
homozygosity ? ? O
mapping ? ? O
came ? ? O
of ? ? O
age ? ? O
, ? ? O
because ? ? O
it ? ? O
could ? ? O
be ? ? O
applied ? ? O
to ? ? O
small ? ? O
( ? ? O
consanguineous ? ? O
) ? ? O
families ? ? O
. ? ? O

Many 22983704 ? O
novel ? ? O
CDG ? ? I-disease
genes ? ? O
have ? ? O
been ? ? O
discovered ? ? O
in ? ? O
this ? ? O
way ? ? O
. ? ? O

But 22983704 ? O
the ? ? O
best ? ? O
has ? ? O
yet ? ? O
to ? ? O
come ? ? O
: ? ? O
what ? ? O
we ? ? O
are ? ? O
currently ? ? O
witnessing ? ? O
, ? ? O
is ? ? O
an ? ? O
explosion ? ? O
of ? ? O
novel ? ? O
CDG ? ? I-disease
defects ? ? O
, ? ? O
thanks ? ? O
to ? ? O
exome ? ? O
sequencing ? ? O
: ? ? O
seven ? ? O
novel ? ? O
types ? ? O
were ? ? O
published ? ? O
over ? ? O
a ? ? O
period ? ? O
of ? ? O
only ? ? O
two ? ? O
years ? ? O
. ? ? O

It 22983704 ? O
is ? ? O
expected ? ? O
that ? ? O
exome ? ? O
sequencing ? ? O
will ? ? O
soon ? ? O
become ? ? O
a ? ? O
diagnostic ? ? O
tool ? ? O
, ? ? O
that ? ? O
will ? ? O
continuously ? ? O
uncover ? ? O
new ? ? O
facets ? ? O
of ? ? O
this ? ? O
fascinating ? ? O
group ? ? O
of ? ? O
diseases ? ? O
. ? ? O

Combined 24069311 ? O
inhibition ? ? O
of ? ? O
p97 ? ? I-gene
and ? ? O
the ? ? O
proteasome ? ? O
causes ? ? O
lethal ? ? O
disruption ? ? O
of ? ? O
the ? ? O
secretory ? ? O
apparatus ? ? O
in ? ? O
multiple ? ? O
myeloma ? ? I-disease
cells ? ? O
. ? ? O

Inhibition 24069311 ? O
of ? ? O
the ? ? O
proteasome ? ? O
is ? ? O
a ? ? O
widely ? ? O
used ? ? O
strategy ? ? O
for ? ? O
treating ? ? O
multiple ? ? I-disease
myeloma ? ? I-disease
that ? ? O
takes ? ? O
advantage ? ? O
of ? ? O
the ? ? O
heavy ? ? O
secretory ? ? O
load ? ? O
that ? ? O
multiple ? ? O
myeloma ? ? O
cells ? ? O
( ? ? O
MMCs ? ? O
) ? ? O
have ? ? O
to ? ? O
deal ? ? O
with ? ? O
. ? ? O

Resistance 24069311 ? O
of ? ? O
MMCs ? ? O
to ? ? O
proteasome ? ? O
inhibition ? ? O
has ? ? O
been ? ? O
linked ? ? O
to ? ? O
incomplete ? ? O
disruption ? ? O
of ? ? O
proteasomal ? ? O
endoplasmic-reticulum ? ? O
( ? ? O
ER ? ? O
) ? ? O
-associated ? ? O
degradation ? ? O
( ? ? O
ERAD ? ? O
) ? ? O
and ? ? O
activation ? ? O
of ? ? O
non-proteasomal ? ? O
protein ? ? O
degradation ? ? O
pathways ? ? O
. ? ? O

The 24069311 ? O
ATPase ? ? O
p97 ? ? I-gene
( ? ? O
VCP ? ? O
/ ? ? O
Cdc48 ? ? I-treatment
) ? ? O
has ? ? O
key ? ? O
roles ? ? O
in ? ? O
mediating ? ? O
both ? ? O
ERAD ? ? O
and ? ? O
non-proteasomal ? ? O
protein ? ? O
degradation ? ? O
and ? ? O
can ? ? O
be ? ? O
targeted ? ? O
pharmacologically ? ? O
by ? ? O
small ? ? O
molecule ? ? O
inhibition ? ? O
. ? ? O

In 24069311 ? O
this ? ? O
study ? ? O
, ? ? O
we ? ? O
compared ? ? O
the ? ? O
effects ? ? O
of ? ? O
p97 ? ? O
inhibition ? ? O
with ? ? O
Eeyarestatin ? ? O
1 ? ? O
and ? ? O
DBeQ ? ? O
on ? ? O
the ? ? O
secretory ? ? O
apparatus ? ? O
of ? ? O
MMCs ? ? O
with ? ? O
the ? ? O
effects ? ? O
induced ? ? O
by ? ? O
the ? ? O
proteasome ? ? O
inhibitor ? ? O
bortezomib ? ? I-treatment
, ? ? O
and ? ? O
the ? ? O
effects ? ? O
caused ? ? O
by ? ? O
combined ? ? O
inhibition ? ? O
of ? ? O
p97 ? ? I-gene
and ? ? O
the ? ? O
proteasome ? ? O
. ? ? O

We 24069311 ? O
found ? ? O
that ? ? O
p97 ? ? O
inhibition ? ? O
elicits ? ? O
cellular ? ? O
responses ? ? O
that ? ? O
are ? ? O
different ? ? O
from ? ? O
those ? ? O
induced ? ? O
by ? ? O
proteasome ? ? O
inhibition ? ? O
, ? ? O
and ? ? O
that ? ? O
the ? ? O
responses ? ? O
differ ? ? O
considerably ? ? O
between ? ? O
MMC ? ? O
lines ? ? O
. ? ? O

Moreover 24069311 ? O
, ? ? O
we ? ? O
found ? ? O
that ? ? O
dual ? ? O
inhibition ? ? O
of ? ? O
both ? ? O
p97 ? ? I-gene
and ? ? O
the ? ? O
proteasome ? ? O
terminally ? ? O
disrupts ? ? O
ER ? ? O
configuration ? ? O
and ? ? O
intracellular ? ? O
protein ? ? O
metabolism ? ? O
in ? ? O
MMCs ? ? O
. ? ? O

Dual 24069311 ? O
inhibition ? ? O
of ? ? O
p97 ? ? O
and ? ? O
the ? ? O
proteasome ? ? O
induced ? ? O
high ? ? O
levels ? ? O
of ? ? O
apoptosis ? ? O
in ? ? O
all ? ? O
of ? ? O
the ? ? O
MMC ? ? I-treatment
lines ? ? O
that ? ? O
we ? ? O
analysed ? ? O
, ? ? O
including ? ? O
bortezomib-adapted ? ? O
AMO-1 ? ? O
cells ? ? O
, ? ? O
and ? ? O
was ? ? O
also ? ? O
effective ? ? O
in ? ? O
killing ? ? O
primary ? ? O
MMCs ? ? O
. ? ? O

Only 24069311 ? O
minor ? ? O
toxicity ? ? I-disease
was ? ? O
observed ? ? O
in ? ? O
untransformed ? ? O
and ? ? O
non-secretory ? ? O
cells ? ? O
. ? ? O

Our 24069311 ? O
observations ? ? O
highlight ? ? O
non-redundant ? ? O
roles ? ? O
of ? ? O
p97 ? ? I-gene
and ? ? O
the ? ? O
proteasome ? ? O
in ? ? O
maintaining ? ? O
secretory ? ? O
homeostasis ? ? O
in ? ? O
MMCs ? ? O
and ? ? O
provide ? ? O
a ? ? O
preclinical ? ? O
conceptual ? ? O
framework ? ? O
for ? ? O
dual ? ? O
targeting ? ? O
of ? ? O
p97 ? ? O
and ? ? O
the ? ? O
proteasome ? ? O
as ? ? O
a ? ? O
potential ? ? O
new ? ? O
therapeutic ? ? O
strategy ? ? O
in ? ? O
multiple ? ? O
myeloma ? ? O
. ? ? O

Increased 24095727 ? O
autophagy ? ? O
in ? ? O
peripheral ? ? O
nerves ? ? O
may ? ? O
protect ? ? O
Wistar ? ? O
Ottawa ? ? O
Karlsburg ? ? O
W ? ? O
rats ? ? O
against ? ? O
neuropathy ? ? I-disease
. ? ? O

OBJECTIVE 24095727 ? O
: ? ? O
Wistar ? ? O
Ottawa ? ? O
Karlsburg ? ? O
W ? ? O
( ? ? O
RT1 ? ? O
( ? ? O
u ? ? O
) ? ? O
) ? ? O
rats ? ? O
( ? ? O
WOKW ? ? O
) ? ? O
develop ? ? O
obesity ? ? I-disease
, ? ? O
dyslipidemia ? ? I-disease
, ? ? O
moderate ? ? O
hypertension ? ? I-disease
, ? ? O
hyperinsulinemia ? ? I-disease
and ? ? O
impaired ? ? I-disease
glucose ? ? I-disease
tolerance ? ? I-disease
prone ? ? O
to ? ? O
induce ? ? O
peripheral ? ? I-disease
neuropathy ? ? I-disease
( ? ? O
PN ? ? I-disease
) ? ? O
. ? ? O

Autophagy 24095727 ? O
has ? ? O
been ? ? O
shown ? ? O
to ? ? O
prevent ? ? O
neurodegeneration ? ? I-disease
in ? ? I-disease
the ? ? I-disease
central ? ? I-disease
and ? ? I-disease
peripheral ? ? I-disease
nervous ? ? I-disease
system ? ? I-disease
. ? ? O

We 24095727 ? O
analyzed ? ? O
the ? ? O
potential ? ? O
protective ? ? O
role ? ? O
of ? ? O
autophagy ? ? O
in ? ? O
an ? ? O
established ? ? O
rat ? ? O
model ? ? O
in ? ? O
preventing ? ? O
PN ? ? O
. ? ? O

METHODS 24095727 ? O
: ? ? O
We ? ? O
examined ? ? O
electrophysiology ? ? O
( ? ? O
motor-and ? ? O
sensory ? ? O
/ ? ? O
mixed ? ? O
afferent ? ? O
conduction ? ? O
velocities ? ? O
and ? ? O
the ? ? O
minimal ? ? O
F-wave ? ? O
latency ? ? O
) ? ? O
and ? ? O
morphology ? ? O
, ? ? O
including ? ? O
ultrathin ? ? O
sections ? ? O
, ? ? O
myelin ? ? O
sheath ? ? O
thickness ? ? O
( ? ? O
g-ratio ? ? O
) ? ? O
and ? ? O
immunohistochemical ? ? O
markers ? ? O
of ? ? O
autophagy ? ? I-disease
and ? ? O
inflammation ? ? I-disease
in ? ? O
the ? ? O
sciatic ? ? O
nerve ? ? O
of ? ? O
five-month-old ? ? O
, ? ? O
male ? ? O
WOKW ? ? O
as ? ? O
compared ? ? O
to ? ? O
Wistar ? ? O
derived ? ? O
, ? ? O
congenic ? ? O
LEW.1W ? ? O
control ? ? O
rats ? ? O
, ? ? O
characterized ? ? O
by ? ? O
the ? ? O
same ? ? O
major ? ? O
histocompatibility ? ? O
complex ? ? O
as ? ? O
WOKW ? ? O
rats ? ? O
( ? ? O
RT1 ? ? O
( ? ? O
u ? ? O
) ? ? O
) ? ? O
. ? ? O

Moreover 24095727 ? O
, ? ? O
the ? ? O
expression ? ? O
of ? ? O
axonal ? ? O
and ? ? O
synaptic ? ? O
proteins ? ? O
( ? ? O
NF68 ? ? I-gene
, ? ? O
GAP43 ? ? I-gene
, ? ? O
MP0 ? ? I-gene
) ? ? O
, ? ? O
autophagy- ? ? O
( ? ? O
Atg5 ? ? I-gene
, ? ? O
Atg7 ? ? I-gene
, ? ? O
LC3 ? ? I-gene
) ? ? O
, ? ? O
and ? ? O
apoptosis ? ? O
( ? ? O
cleaved ? ? I-gene
caspase-3 ? ? I-gene
) ? ? O
-related ? ? O
markers ? ? O
was ? ? O
measured ? ? O
using ? ? O
Western ? ? O
blot ? ? O
. ? ? O

RESULTS 24095727 ? O
: ? ? O
No ? ? O
abnormalities ? ? O
in ? ? O
nerve ? ? O
electrophysiology ? ? O
and ? ? O
morphology ? ? O
were ? ? O
found ? ? O
in ? ? O
WOKW ? ? O
compared ? ? O
to ? ? O
LEW.1W ? ? O
rats ? ? O
. ? ? O

However 24095727 ? O
, ? ? O
autophagosomes ? ? O
were ? ? O
more ? ? O
frequently ? ? O
apparent ? ? O
in ? ? O
sciatic ? ? O
nerves ? ? O
of ? ? O
WOKW ? ? O
rats ? ? O
. ? ? O

In 24095727 ? O
Western ? ? O
blot ? ? O
analyses ? ? O
no ? ? O
significant ? ? O
differences ? ? O
in ? ? O
expression ? ? O
of ? ? O
neuronal ? ? O
structural ? ? O
proteins ? ? O
were ? ? O
found ? ? O
, ? ? O
but ? ? O
autophagy ? ? O
markers ? ? O
were ? ? O
up-regulated ? ? O
in ? ? O
WOKW ? ? O
compared ? ? O
to ? ? O
LEW.1W ? ? O
sciatic ? ? O
nerves ? ? O
. ? ? O

Immunostaining 24095727 ? O
revealed ? ? O
a ? ? O
greater ? ? O
infiltration ? ? O
of ? ? O
Iba1 ? ? O
/ ? ? O
ED-1-positive ? ? O
macrophages ? ? O
, ? ? O
CD-3-positive ? ? O
T-cells ? ? O
and ? ? O
LC3-expression ? ? O
in ? ? O
sciatic ? ? O
nerves ? ? O
of ? ? O
WOKW ? ? O
rats ? ? O
. ? ? O

CONCLUSIONS 24095727 ? O
: ? ? O
Our ? ? O
results ? ? O
indicate ? ? O
that ? ? O
WOKW ? ? O
rats ? ? O
show ? ? O
an ? ? O
up-regulated ? ? O
autophagy ? ? O
and ? ? O
a ? ? O
mild ? ? O
inflammatory ? ? O
response ? ? O
but ? ? O
do ? ? O
not ? ? O
develop ? ? O
overt ? ? O
neuropathy ? ? I-disease
. ? ? O

We 24095727 ? O
suggest ? ? O
that ? ? O
autophagy ? ? O
and ? ? O
inflammatory ? ? O
cells ? ? O
may ? ? O
exert ? ? O
a ? ? O
protective ? ? O
role ? ? O
in ? ? O
preventing ? ? O
neuropathy ? ? I-disease
in ? ? O
this ? ? O
rat ? ? O
model ? ? O
of ? ? O
the ? ? O
metabolic ? ? I-disease
syndrome ? ? I-disease
but ? ? O
the ? ? O
mechanism ? ? O
of ? ? O
action ? ? O
is ? ? O
still ? ? O
unclear ? ? O
. ? ? O

Pharmacological 26104798 ? O
targeting ? ? O
of ? ? O
valosin ? ? I-gene
containing ? ? I-gene
protein ? ? I-gene
( ? ? O
VCP ? ? O
) ? ? O
induces ? ? O
DNA ? ? O
damage ? ? O
and ? ? O
selectively ? ? O
kills ? ? O
canine ? ? O
lymphoma ? ? O
cells ? ? O
. ? ? O

BACKGROUND 26104798 ? O
: ? ? O
Valosin ? ? I-gene
containing ? ? I-gene
protein ? ? I-gene
( ? ? O
VCP ? ? O
) ? ? O
is ? ? O
a ? ? O
critical ? ? O
mediator ? ? O
of ? ? O
protein ? ? O
homeostasis ? ? O
and ? ? O
may ? ? O
represent ? ? O
a ? ? O
valuable ? ? O
therapeutic ? ? O
target ? ? O
for ? ? O
several ? ? O
forms ? ? O
of ? ? O
cancer ? ? O
. ? ? O

Overexpression 26104798 ? O
of ? ? O
VCP ? ? I-gene
occurs ? ? O
in ? ? O
many ? ? O
cancers ? ? I-disease
, ? ? O
and ? ? O
often ? ? O
in ? ? O
a ? ? O
manner ? ? O
correlating ? ? O
with ? ? O
malignancy ? ? O
and ? ? O
poor ? ? O
outcome ? ? O
. ? ? O

Here 26104798 ? O
, ? ? O
we ? ? O
analyzed ? ? O
VCP ? ? O
expression ? ? O
in ? ? O
canine ? ? O
lymphoma ? ? I-disease
and ? ? O
assessed ? ? O
its ? ? O
potential ? ? O
as ? ? O
a ? ? O
therapeutic ? ? O
target ? ? O
for ? ? O
this ? ? O
disease ? ? O
. ? ? O

METHODS 26104798 ? O
: ? ? O
VCP ? ? I-gene
expression ? ? O
in ? ? O
canine ? ? O
lymphomas ? ? O
was ? ? O
evaluated ? ? O
by ? ? O
immunoblotting ? ? O
and ? ? O
immunohistochemistry ? ? O
. ? ? O

The 26104798 ? O
canine ? ? O
lymphoma ? ? I-disease
cell ? ? O
lines ? ? O
CLBL-1 ? ? O
, ? ? O
17-71 ? ? O
and ? ? O
CL-1 ? ? O
were ? ? O
treated ? ? O
with ? ? O
the ? ? O
VCP ? ? I-gene
inhibitor ? ? O
Eeyarestatin ? ? O
1 ? ? O
( ? ? O
EER-1 ? ? O
) ? ? O
at ? ? O
varying ? ? O
concentrations ? ? O
and ? ? O
times ? ? O
and ? ? O
were ? ? O
assessed ? ? O
for ? ? O
viability ? ? O
by ? ? O
trypan ? ? I-treatment
blue ? ? I-treatment
exclusion ? ? O
, ? ? O
apoptosis ? ? O
by ? ? O
TUNEL ? ? O
and ? ? O
caspase ? ? O
activity ? ? O
assays ? ? O
, ? ? O
and ? ? O
proliferation ? ? O
by ? ? O
propidium ? ? O
iodide ? ? O
incorporation ? ? O
and ? ? O
FACS ? ? O
. ? ? O

The 26104798 ? O
mechanism ? ? O
of ? ? O
EER-1 ? ? O
action ? ? O
was ? ? O
determined ? ? O
by ? ? O
immunoblotting ? ? O
and ? ? O
immunofluorescence ? ? O
analyses ? ? O
of ? ? O
Lys48 ? ? O
ubiquitin ? ? O
and ? ? O
markers ? ? O
of ? ? O
ER ? ? O
stress ? ? O
( ? ? O
DDIT3 ? ? O
) ? ? O
, ? ? O
autophagy ? ? O
( ? ? O
SQSTM1 ? ? I-gene
, ? ? O
MAP1LC3A ? ? O
) ? ? O
and ? ? O
DNA ? ? O
damage ? ? O
( ? ? O
gammaH2AFX ? ? I-treatment
) ? ? O
. ? ? O

TRP53 26104798 ? I-gene
/ ? ? O
ATM-dependent ? ? O
signaling ? ? O
pathway ? ? O
activity ? ? O
was ? ? O
assessed ? ? O
by ? ? O
immunoblotting ? ? O
for ? ? O
TRP53 ? ? I-gene
and ? ? O
phospho-TRP53 ? ? O
and ? ? O
real-time ? ? O
RT-PCR ? ? O
measurement ? ? O
of ? ? O
Cdkn1a ? ? I-gene
mRNA ? ? O
. ? ? O

RESULTS 26104798 ? O
: ? ? O
VCP ? ? O
expression ? ? O
levels ? ? O
in ? ? O
canine ? ? O
B ? ? O
cell ? ? O
lymphomas ? ? O
were ? ? O
found ? ? O
to ? ? O
increase ? ? O
with ? ? O
grade ? ? O
. ? ? O

EER-1 26104798 ? O
treatment ? ? O
killed ? ? O
canine ? ? O
lymphoma ? ? O
cells ? ? O
preferentially ? ? O
over ? ? O
control ? ? O
peripheral ? ? O
blood ? ? O
mononuclear ? ? O
cells ? ? O
. ? ? O

EER-1 26104798 ? O
treatment ? ? O
of ? ? O
CLBL-1 ? ? O
cells ? ? O
was ? ? O
found ? ? O
to ? ? O
both ? ? O
induce ? ? O
apoptosis ? ? O
and ? ? O
cell ? ? O
cycle ? ? O
arrest ? ? O
in ? ? O
G1 ? ? O
. ? ? O

Unexpectedly 26104798 ? O
, ? ? O
EER-1 ? ? O
did ? ? O
not ? ? O
appear ? ? O
to ? ? O
act ? ? O
either ? ? O
by ? ? O
inducing ? ? O
ER ? ? O
stress ? ? O
or ? ? O
inhibiting ? ? O
the ? ? O
aggresome-autophagy ? ? O
pathway ? ? O
. ? ? O

Rather 26104798 ? O
, ? ? O
a ? ? O
rapid ? ? O
and ? ? O
dramatic ? ? O
increase ? ? O
in ? ? O
gammaH2AFX ? ? O
expression ? ? O
was ? ? O
noted ? ? O
, ? ? O
indicating ? ? O
that ? ? O
EER-1 ? ? O
may ? ? O
act ? ? O
by ? ? O
promoting ? ? O
DNA ? ? O
damage ? ? O
accumulation ? ? O
. ? ? O

Increased 26104798 ? O
TRP53 ? ? I-gene
phosphorylation ? ? O
and ? ? O
Cdkn1a ? ? O
mRNA ? ? O
levels ? ? O
indicated ? ? O
an ? ? O
activation ? ? O
of ? ? O
the ? ? O
TRP53 ? ? I-gene
/ ? ? O
ATM ? ? O
DNA ? ? O
damage ? ? O
response ? ? O
pathway ? ? O
in ? ? O
response ? ? O
to ? ? O
EER-1 ? ? O
, ? ? O
likely ? ? O
contributing ? ? O
to ? ? O
the ? ? O
induction ? ? O
of ? ? O
apoptosis ? ? O
and ? ? O
cell ? ? O
cycle ? ? O
arrest ? ? O
. ? ? O

CONCLUSIONS 26104798 ? O
: ? ? O
These ? ? O
results ? ? O
correlate ? ? O
VCP ? ? I-gene
expression ? ? O
with ? ? O
malignancy ? ? I-disease
in ? ? O
canine ? ? O
B ? ? O
cell ? ? O
lymphoma ? ? O
. ? ? O

The 26104798 ? O
selective ? ? O
activity ? ? O
of ? ? O
EER-1 ? ? O
against ? ? O
lymphoma ? ? I-disease
cells ? ? O
suggests ? ? O
that ? ? O
VCP ? ? O
will ? ? O
represent ? ? O
a ? ? O
clinically ? ? O
useful ? ? O
therapeutic ? ? O
target ? ? O
for ? ? O
the ? ? O
treatment ? ? O
of ? ? O
lymphoma ? ? O
. ? ? O

We 26104798 ? O
further ? ? O
suggest ? ? O
a ? ? O
mechanism ? ? O
of ? ? O
EER-1 ? ? O
action ? ? O
centered ? ? O
on ? ? O
the ? ? O
DNA ? ? O
repair ? ? O
response ? ? O
that ? ? O
may ? ? O
be ? ? O
of ? ? O
central ? ? O
importance ? ? O
for ? ? O
the ? ? O
design ? ? O
and ? ? O
characterization ? ? O
of ? ? O
VCP ? ? I-gene
inhibitory ? ? O
compounds ? ? O
for ? ? O
therapeutic ? ? O
use ? ? O
. ? ? O

Synthesis 26118368 ? O
of ? ? O
Fluorophores ? ? O
that ? ? O
Target ? ? O
Small ? ? O
Molecules ? ? O
to ? ? O
the ? ? O
Endoplasmic ? ? O
Reticulum ? ? O
of ? ? O
Living ? ? O
Mammalian ? ? O
Cells ? ? O
. ? ? O

The 26118368 ? O
endoplasmic ? ? O
reticulum ? ? O
( ? ? O
ER ? ? O
) ? ? O
plays ? ? O
critical ? ? O
roles ? ? O
in ? ? O
the ? ? O
processing ? ? O
of ? ? O
secreted ? ? O
and ? ? O
transmembrane ? ? O
proteins ? ? O
. ? ? O

To 26118368 ? O
deliver ? ? O
small ? ? O
molecules ? ? O
to ? ? O
this ? ? O
organelle ? ? O
, ? ? O
we ? ? O
synthesized ? ? O
fluorinated ? ? O
hydrophobic ? ? O
analogues ? ? O
of ? ? O
the ? ? O
fluorophore ? ? O
rhodol ? ? I-treatment
. ? ? O

These 26118368 ? O
cell-permeable ? ? O
fluorophores ? ? O
are ? ? O
exceptionally ? ? O
bright ? ? O
, ? ? O
with ? ? O
quantum ? ? O
yields ? ? O
of ? ? O
around ? ? O
0.8 ? ? O
, ? ? O
and ? ? O
they ? ? O
were ? ? O
found ? ? O
to ? ? O
specifically ? ? O
accumulate ? ? O
in ? ? O
the ? ? O
ER ? ? O
of ? ? O
living ? ? O
HeLa ? ? O
cells ? ? O
, ? ? O
as ? ? O
imaged ? ? O
by ? ? O
confocal ? ? O
laser ? ? O
scanning ? ? O
microscopy ? ? O
. ? ? O

To 26118368 ? O
target ? ? O
a ? ? O
biological ? ? O
pathway ? ? O
controlled ? ? O
by ? ? O
the ? ? O
ER ? ? O
, ? ? O
we ? ? O
linked ? ? O
a ? ? O
fluorinated ? ? I-treatment
hydrophobic ? ? I-treatment
rhodol ? ? I-treatment
to ? ? O
5-nitrofuran-2-acrylaldehyde ? ? I-treatment
. ? ? O

In 26118368 ? O
contrast ? ? O
to ? ? O
an ? ? O
untargeted ? ? O
nitrofuran ? ? I-treatment
warhead ? ? O
, ? ? O
delivery ? ? O
of ? ? O
this ? ? O
electrophilic ? ? I-treatment
nitrofuran ? ? I-treatment
to ? ? O
the ? ? O
ER ? ? O
by ? ? O
the ? ? O
rhodol ? ? I-treatment
resulted ? ? O
in ? ? O
cytotoxicity ? ? O
comparable ? ? O
to ? ? O
the ? ? O
ER-targeted ? ? O
cytotoxin ? ? I-treatment
eeyarestatin ? ? I-treatment
I ? ? I-treatment
, ? ? O
and ? ? O
specifically ? ? O
inhibited ? ? O
protein ? ? O
processing ? ? O
by ? ? O
the ? ? O
ubiquitin-proteasome ? ? O
system ? ? O
. ? ? O

Fluorinated 26118368 ? I-treatment
hydrophobic ? ? I-treatment
rhodols ? ? I-treatment
are ? ? O
outstanding ? ? O
fluorophores ? ? O
that ? ? O
enable ? ? O
the ? ? O
delivery ? ? O
of ? ? O
small ? ? O
molecules ? ? O
for ? ? O
targeting ? ? O
ER-associated ? ? O
proteins ? ? O
and ? ? O
pathways ? ? O
. ? ? O

Group 26928153 ? O
B ? ? O
streptococcus ? ? O
alters ? ? O
properties ? ? O
of ? ? O
vaginal ? ? O
epithelial ? ? O
cells ? ? O
in ? ? O
pregnant ? ? O
women ? ? O
. ? ? O

BACKGROUND 26928153 ? O
: ? ? O
Group ? ? I-disease
B ? ? I-disease
streptococcus ? ? I-disease
( ? ? O
GBS ? ? I-disease
) ? ? O
infection ? ? O
in ? ? O
pregnancy ? ? O
is ? ? O
a ? ? O
major ? ? O
cause ? ? O
of ? ? O
maternal ? ? O
and ? ? O
neonatal ? ? O
morbidity ? ? O
. ? ? O

An 26928153 ? O
understanding ? ? O
of ? ? O
the ? ? O
mechanisms ? ? O
responsible ? ? O
for ? ? O
GBS ? ? I-disease
persistence ? ? O
in ? ? O
the ? ? O
genital ? ? O
tract ? ? O
, ? ? O
as ? ? O
well ? ? O
as ? ? O
recognition ? ? O
of ? ? O
host ? ? O
defenses ? ? O
employed ? ? O
to ? ? O
combat ? ? O
its ? ? O
presence ? ? O
, ? ? O
are ? ? O
crucial ? ? O
to ? ? O
our ? ? O
efforts ? ? O
to ? ? O
reduce ? ? O
maternal ? ? O
GBS ? ? I-disease
colonization ? ? O
and ? ? O
prevent ? ? O
the ? ? O
acquisition ? ? O
of ? ? O
neonatal ? ? I-disease
infections ? ? I-disease
. ? ? O

However 26928153 ? O
, ? ? O
alterations ? ? O
in ? ? O
vaginal ? ? O
immunity ? ? O
in ? ? O
response ? ? O
to ? ? O
GBS ? ? I-disease
colonization ? ? O
in ? ? O
pregnant ? ? O
women ? ? O
remain ? ? O
incompletely ? ? O
defined ? ? O
. ? ? O

Whether 26928153 ? O
GBS ? ? I-disease
modulates ? ? O
autophagy ? ? O
, ? ? O
a ? ? O
major ? ? O
host ? ? O
defense ? ? O
mechanism ? ? O
and ? ? O
contributor ? ? O
to ? ? O
the ? ? O
control ? ? O
of ? ? O
intracellular ? ? O
microbial ? ? O
infections ? ? O
, ? ? O
also ? ? O
remains ? ? O
unclear ? ? O
. ? ? O

OBJECTIVE 26928153 ? O
: ? ? O
We ? ? O
sought ? ? O
to ? ? O
identify ? ? O
differences ? ? O
in ? ? O
the ? ? O
extent ? ? O
of ? ? O
autophagy ? ? O
as ? ? O
well ? ? O
as ? ? O
in ? ? O
the ? ? O
concentration ? ? O
of ? ? O
biomarkers ? ? O
previously ? ? O
shown ? ? O
to ? ? O
be ? ? O
involved ? ? O
in ? ? O
vaginal ? ? O
innate ? ? O
immunity ? ? O
between ? ? O
GBS-positive ? ? O
and ? ? O
GBS-negative ? ? O
pregnant ? ? O
women ? ? O
. ? ? O

STUDY 26928153 ? O
DESIGN ? ? O
: ? ? O
We ? ? O
performed ? ? O
a ? ? O
prospective ? ? O
cohort ? ? O
study ? ? O
of ? ? O
healthy ? ? O
pregnant ? ? O
women ? ? O
, ? ? O
who ? ? O
had ? ? O
vaginal ? ? O
secretions ? ? O
obtained ? ? O
at ? ? O
35-37 ? ? O
weeks ? ? O
of ? ? O
gestation ? ? O
, ? ? O
just ? ? O
prior ? ? O
to ? ? O
the ? ? O
standard ? ? O
GBS ? ? I-disease
rectovaginal ? ? O
sample ? ? O
collection ? ? O
. ? ? O

The 26928153 ? O
contents ? ? O
of ? ? O
the ? ? O
swabs ? ? O
were ? ? O
released ? ? O
into ? ? O
tubes ? ? O
containing ? ? O
1 ? ? O
mL ? ? O
of ? ? O
sterile ? ? O
phosphate-buffered ? ? O
saline ? ? O
. ? ? O

Samples 26928153 ? O
were ? ? O
centrifuged ? ? O
, ? ? O
and ? ? O
supernatant ? ? O
and ? ? O
cell ? ? O
pellet ? ? O
fractions ? ? O
were ? ? O
collected ? ? O
and ? ? O
stored ? ? O
separately ? ? O
at ? ? O
-80 ? ? O
degrees ? ? O
C ? ? O
until ? ? O
used ? ? O
for ? ? O
analysis ? ? O
. ? ? O

Epithelial 26928153 ? O
cells ? ? O
were ? ? O
then ? ? O
lysed ? ? O
, ? ? O
and ? ? O
the ? ? O
extent ? ? O
of ? ? O
autophagy ? ? O
was ? ? O
determined ? ? O
by ? ? O
measuring ? ? O
the ? ? O
residual ? ? O
level ? ? O
of ? ? O
p62 ? ? I-gene
remaining ? ? O
in ? ? O
the ? ? O
cytoplasm ? ? O
. ? ? O

p62 26928153 ? I-gene
is ? ? O
a ? ? O
protein ? ? O
that ? ? O
is ? ? O
consumed ? ? O
during ? ? O
autophagy ? ? O
, ? ? O
and ? ? O
so ? ? O
its ? ? O
concentration ? ? O
detectable ? ? O
in ? ? O
the ? ? O
cytoplasm ? ? O
is ? ? O
inversely ? ? O
related ? ? O
to ? ? O
the ? ? O
extent ? ? O
of ? ? O
autophagy ? ? O
induction ? ? O
. ? ? O

The 26928153 ? O
intracellular ? ? O
level ? ? O
of ? ? O
the ? ? O
inducible ? ? O
70-kDa ? ? O
heat ? ? O
shock ? ? O
protein ? ? O
( ? ? O
hsp70 ? ? O
) ? ? O
, ? ? O
an ? ? O
inhibitor ? ? O
of ? ? O
autophagy ? ? O
, ? ? O
was ? ? O
also ? ? O
measured ? ? O
. ? ? O

The 26928153 ? O
cell-free ? ? O
fraction ? ? O
was ? ? O
assayed ? ? O
for ? ? O
D- ? ? O
and ? ? O
L-lactic ? ? O
acid ? ? O
, ? ? O
neutrophil ? ? O
gelatinase-associated ? ? O
lipocalin ? ? O
, ? ? O
extracellular ? ? O
matrix ? ? O
metalloproteinase ? ? O
inducer ? ? O
( ? ? O
EMMPRIN ? ? O
) ? ? O
, ? ? O
matrix ? ? I-gene
metalloproteinase ? ? I-gene
( ? ? I-gene
MMP ? ? I-gene
) ? ? I-gene
-8 ? ? I-gene
, ? ? O
alpha ? ? I-gene
amylase ? ? I-gene
, ? ? O
hyaluronan ? ? I-gene
, ? ? O
and ? ? O
total ? ? O
protein ? ? O
. ? ? O

Laboratory 26928153 ? O
personnel ? ? O
were ? ? O
blinded ? ? O
to ? ? O
all ? ? O
clinical ? ? O
data ? ? O
. ? ? O

RESULTS 26928153 ? O
: ? ? O
There ? ? O
were ? ? O
145 ? ? O
women ? ? O
included ? ? O
in ? ? O
the ? ? O
study ? ? O
, ? ? O
of ? ? O
which ? ? O
45 ? ? O
( ? ? O
31 ? ? O
% ? ? O
) ? ? O
were ? ? O
culture-positive ? ? O
for ? ? O
GBS ? ? I-disease
. ? ? O

Vaginal 26928153 ? O
cells ? ? O
from ? ? O
GBS-positive ? ? O
women ? ? O
had ? ? O
elevated ? ? O
intracellular ? ? O
levels ? ? O
of ? ? O
p62 ? ? O
( ? ? O
2.1 ? ? O
vs ? ? O
0.7 ? ? O
pg ? ? O
/ ? ? O
mL ? ? O
, ? ? O
P ? ? O
< ? ? O
.01 ? ? O
) ? ? O
and ? ? O
hsp70 ? ? O
( ? ? O
16.9 ? ? O
vs ? ? O
9.6 ? ? O
ng ? ? O
/ ? ? O
mL ? ? O
, ? ? O
P ? ? O
= ? ? O
.03 ? ? O
) ? ? O
as ? ? O
compared ? ? O
to ? ? O
GBS-negative ? ? O
women ? ? O
. ? ? O

The 26928153 ? O
p62 ? ? I-gene
and ? ? O
hsp70 ? ? I-gene
levels ? ? O
were ? ? O
highly ? ? O
correlated ? ? O
in ? ? O
both ? ? O
groups ? ? O
of ? ? O
subjects ? ? O
( ? ? O
P ? ? O
< ? ? O
.01 ? ? O
) ? ? O
. ? ? O

In 26928153 ? O
vaginal ? ? O
fluid ? ? O
, ? ? O
concentrations ? ? O
of ? ? O
neutrophil ? ? O
gelatinase-associated ? ? O
lipocalin ? ? O
( ? ? O
1.1 ? ? O
vs ? ? O
0.7 ? ? O
ng ? ? O
/ ? ? O
mug ? ? O
total ? ? O
protein ? ? O
, ? ? O
P ? ? O
= ? ? O
.01 ? ? O
) ? ? O
, ? ? O
MMP-8 ? ? O
( ? ? O
21.9 ? ? O
vs ? ? O
11.1 ? ? O
pg ? ? O
/ ? ? O
mug ? ? O
total ? ? O
protein ? ? O
, ? ? O
P ? ? O
= ? ? O
.01 ? ? O
) ? ? O
, ? ? O
and ? ? O
extracellular ? ? O
MMP ? ? O
inducer ? ? O
( ? ? O
8.8 ? ? O
vs ? ? O
7.2 ? ? O
pg ? ? O
/ ? ? O
mug ? ? O
total ? ? O
protein ? ? O
, ? ? O
P ? ? O
= ? ? O
.03 ? ? O
) ? ? O
were ? ? O
highest ? ? O
in ? ? O
GBS-positive ? ? O
women ? ? O
. ? ? O

There 26928153 ? O
were ? ? O
no ? ? O
differences ? ? O
in ? ? O
the ? ? O
concentrations ? ? O
of ? ? O
D- ? ? O
and ? ? O
L-lactic ? ? O
acid ? ? O
, ? ? O
alpha ? ? I-gene
amylase ? ? I-gene
, ? ? O
or ? ? O
hyaluronan ? ? I-gene
between ? ? O
the ? ? O
2 ? ? O
groups ? ? O
of ? ? O
women ? ? O
. ? ? O

CONCLUSION 26928153 ? O
: ? ? O
The ? ? O
inhibition ? ? O
of ? ? O
autophagy ? ? O
in ? ? O
vaginal ? ? O
epithelial ? ? O
cells ? ? O
by ? ? O
GBS-induced ? ? O
hsp70 ? ? O
production ? ? O
is ? ? O
associated ? ? O
with ? ? O
its ? ? O
persistence ? ? O
. ? ? O

Concurrently 26928153 ? O
, ? ? O
alterations ? ? O
in ? ? O
components ? ? O
known ? ? O
to ? ? O
influence ? ? O
vaginal ? ? O
bacterial ? ? O
colonization ? ? O
or ? ? O
facilitate ? ? O
microbial ? ? O
passage ? ? O
to ? ? O
the ? ? O
upper ? ? O
genital ? ? O
tract ? ? O
also ? ? O
occur ? ? O
in ? ? O
relation ? ? O
to ? ? O
GBS ? ? I-disease
carriage ? ? O
. ? ? O

